146 related articles for article (PubMed ID: 15260134)
1. Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus.
D'Amico M; Cannizzaro C; Preziosi P; Martire M
Neurochem Res; 2004 Aug; 29(8):1553-61. PubMed ID: 15260134
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action.
Köfalvi A; Vizi ES; Ledent C; Sperlágh B
Eur J Neurosci; 2003 Oct; 18(7):1973-8. PubMed ID: 14622229
[TBL] [Abstract][Full Text] [Related]
3. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus.
Cannizzaro C; D'Amico M; Preziosi P; Martire M
Neurochem Int; 2006 Feb; 48(3):159-65. PubMed ID: 16325966
[TBL] [Abstract][Full Text] [Related]
5. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
6. Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus.
Köfalvi A; Pereira MF; Rebola N; Rodrigues RJ; Oliveira CR; Cunha RA
Br J Pharmacol; 2007 Jun; 151(4):551-63. PubMed ID: 17435795
[TBL] [Abstract][Full Text] [Related]
7. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
Kelley BG; Thayer SA
Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain.
Cenni G; Blandina P; Mackie K; Nosi D; Formigli L; Giannoni P; Ballini C; Della Corte L; Mannaioni PF; Passani MB
Eur J Neurosci; 2006 Sep; 24(6):1633-44. PubMed ID: 17004927
[TBL] [Abstract][Full Text] [Related]
9. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
10. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
11. Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum.
Kurjak M; Hamel AM; Allescher HD; Schusdziarra V; Storr M
Neuropeptides; 2008; 42(5-6):623-32. PubMed ID: 18829105
[TBL] [Abstract][Full Text] [Related]
12. Effects of oxiracetam on neurotransmitter release from rat hippocampus slices and synaptosomes.
Raiteri M; Costa R; Marchi M
Neurosci Lett; 1992 Sep; 145(1):109-13. PubMed ID: 1361044
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids.
Breivogel CS; Walker JM; Huang SM; Roy MB; Childers SR
Neuropharmacology; 2004 Jul; 47(1):81-91. PubMed ID: 15165836
[TBL] [Abstract][Full Text] [Related]
15. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
Cadogan AK; Alexander SP; Boyd EA; Kendall DA
J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
[TBL] [Abstract][Full Text] [Related]
16. CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices.
Landucci E; Scartabelli T; Gerace E; Moroni F; Pellegrini-Giampietro DE
Neuropharmacology; 2011 Mar; 60(4):674-82. PubMed ID: 21130785
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release.
Bari M; Bonifacino T; Milanese M; Spagnuolo P; Zappettini S; Battista N; Giribaldi F; Usai C; Bonanno G; Maccarrone M
Cell Mol Life Sci; 2011 Mar; 68(5):833-45. PubMed ID: 20711816
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum.
Begg M; Molleman A; Parsons M
Eur J Pharmacol; 2002 Jan; 434(1-2):87-94. PubMed ID: 11755170
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
Twitchell W; Brown S; Mackie K
J Neurophysiol; 1997 Jul; 78(1):43-50. PubMed ID: 9242259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
